CoChat

Fear of cancer recurrence eight years after early-stage breast cancer – results from a national survey

Open access

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Fear of cancer recurrence (FCR) in breast cancer survivors (BCSs) is common, associated with reduced quality of life and effective interventions exist. There are knowledge gaps concerning FCR among long-term, early-stage BCSs and its associations with other late effects. Within a national cohort, we explored these knowledge gaps, with the ultimate aim of improved care for BCSs experiencing long-term FCR. METHODS: = 2803), were identified by the Cancer Registry of Norway in 2019 and mailed a survey including the Assessment of Survivor Concerns used to measure FCR. Factors associated with moderate/high FCR (defined as a sum score of ≥ 6 of a possible range 3-12, or a single score on one of the items of ≥ 3) were explored using a three-block regression analyses including relevant sociodemographic-, health- and cancer-related variables. RESULTS: In total, 1311 BCSs were included (47%). Median age at survey was 60 years. Fifty-six % reported moderate-to-high FCR, associated with younger age (OR 0.96, 95% CI 0.95-0.97) and receiving chemo- and endocrine therapy (OR 1.59, 95% CI 1.15-2.20). After adding late effects into the model, FCR remained significantly associated with these variables, in addition to sleep disturbances (OR 1.58, 95% CI 1.18-2.10). In the final block, adding mental distress, FCR remained significantly associated with younger age (OR 0.97, 95% CI 0.96-0.99), receiving chemo- and endocrine therapy (OR 1.14, 95% CI 1.00-1.97), sleep disturbances (OR 1.44, 95% CI 1.08-1.94) and anxiety (OR 2.67, 95% CI 1.38-5.19). CONCLUSIONS: FCR was prevalent eight years after early-stage breast cancer. Being younger, receiving intensive treatment, experiencing sleep disturbances and/or anxiety were associated with moderate/high FCR. Addressing FCR should be part of standard follow-up care of long-term BCSs.

Overview

Integrity signals

Registry

Crossref · 10.1080/0284186x.2023.2224052

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 36 references

Cited by

See all 21

Metadata

Authors
Vandraas, K., Reinertsen, K. V., Smedsland, S., Bøhn, S., Kiserud, C., Falk, R. S., & Lie, H. C.
Affiliations
Oslo University Hospital (NO)
Corresponding author
Vandraas, Kathrine
Venue
Acta Oncologica
Published
2023-06-03
Volume
62
Issue
6
Pages
635-641
ISSN
  • 0284-186X (ISSN-L)
  • 1651-226X
OpenAlex
W4381309655
Cited by
16
References
36
Citations by year
2026: 5 · 2025: 11
FWCI
1.94
Type
journal article
Language
en
Open access
Locations
  • Acta Oncologica (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
Keywords
fear of cancer recurrence, breast cancer survivors, early breast cancer, long-term follow-up, late effects of cancer treatment, chemotherapy, endocrine therapy, sleep disorders, anxiety, psychological distress, age, survivorship care
MeSH terms
Breast Neoplasms, Cross-Sectional Studies, Fear, Female, Humans, Middle Aged, Neoplasm Recurrence, Local, Quality of Life

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fear of cancer recurrence eight years after early-stage breast cancer – results from a national survey. https://app.cochat.ai/papers/10.1080/0284186x.2023.2224052
The paper
Vandraas, K., Reinertsen, K. V., Smedsland, S., Bøhn, S., Kiserud, C., Falk, R. S., & Lie, H. C. (2023). Fear of cancer recurrence eight years after early-stage breast cancer – results from a national survey. Acta Oncologica. https://doi.org/10.1080/0284186x.2023.2224052

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.